Sort
34,240 grants matching “atherosclerosis”
Role of Monoamine Oxidase A and Diet-Induced Monocyte Dysfunction, Macrophage Reprogramming, and Atherosclerosis
$698,411Reto H.r. Asmis · Wake Forest University Health Sciences · R01 · FY2022 · HL
Pharmacogenomic studies in VISP: results & implications for clinical trial design
$698,373Michele M Sale · University Of Virginia · U01 · FY2011 · HG
Hopkins Lupus Cohort
$698,318Michelle A Petri · Johns Hopkins University · R01 · FY2016 · AR
Genetic Susceptibility To Carcinogens
$698,262Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
NHLBI Shared Microarray Facility
$698,234Jackson Laboratory · R01 · FY2002 · HL
Engineering an Atherosclerosis-Resistant Endothelium
$698,204Martin A. Schwartz · University Of Virginia · R01 · FY2008 · HL
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin
$698,193Norrina Allen · Northwestern University · N01 · FY2020 · HL
PeRiodontal treatment to Eliminate Minority InEquality and Rural disparities in Stroke (PREMIERS)
$698,143Souvik Sen · University Of South Carolina At Columbia · R01 · FY2016 · MD
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation
$698,117David Y Hui · University Of Cincinnati · R01 · FY2017 · HL
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation
$698,117David Y Hui · University Of Cincinnati · R01 · FY2016 · HL
Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
$698,084Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2022 · HL
Air Pollution, Intima-media Thickness, and Lung Function in College Students
$698,083Edward Avol · University Of Southern California · R01 · FY2010 · ES
Nanotechnology-based cardiovascular vaccines
$698,017Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2025 · HL
ARTERIAL ENDOTHELIAL FUNCTION--AN EPIDEMIOLOGIC STUDY
$697,986University Of Iowa · R37 · FY2002 · HL
Genetic Studies of The Impact of Hematologic Traits On Cardiovascular Disease
$697,929Santhi K Ganesh · University Of Michigan At Ann Arbor · R01 · FY2017 · HL
Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors
$697,894Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis
$697,873William James Adams · Riparian Pharmaceuticals, Inc. · R44 · FY2018 · HL
HUNTing for myocardial infarction genes by combined genome and exome sequencing
$697,796Cristen J Willer · University Of Michigan At Ann Arbor · R01 · FY2014 · HL
Role of PXR in drug-elicited cardiovascular disease
$697,761Changcheng Zhou · University Of California Riverside · R01 · FY2024 · HL
T Regulatory Lymphocytes, HDL Function, and Atherosclerosis
$697,733Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2015 · HL
Preclinical cardiac imaging package for clinical SPECT systems
$697,516Scott Dean Metzler · University Of Pennsylvania · R01 · FY2014 · HL
Project 3
$697,265Philip N. Benfey · Duke University · P50 · FY2010 · GM
Immune function and the risk of cvd among HIV infected and uninfected veterans
$697,207Matthew S Freiberg · Vanderbilt University Medical Center · R01 · FY2016 · HL
Biomarkers for Complications in Type 1 Diabetes (DCCT/EDIC)
$697,154Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2009 · DK
A Just-In-Time Adaptive Mobile Application Intervention To Reduce Sodium Intake And Blood Pressure In Hypertensive Patients
$697,067Michael Dorsch · University Of Michigan At Ann Arbor · R33 · FY2025 · HL